Sort
50,496 grants matching “lung cancer”
Immuno-Serological Assays for Monitoring COVID19 in Patients with Hematologic Malignancies
$1,137,992Rong Fan · Yale University · U01 · FY2023 · CA
Molecular, Cellular, and Tissue Characterization Unit
$1,137,550Dana Pe'er · Sloan-Kettering Inst Can Research · U2C · FY2019 · CA
Advancing cancer care and equity through telehealth, communication science, and behavioral economics
$1,137,502Justin Bekelman · University Of Pennsylvania · P50 · FY2023 · CA
Advancing cancer care and equity through telehealth, communication science, and behavioral economics
$1,137,500Justin Bekelman · University Of Pennsylvania · P50 · FY2022 · CA
Multiscale Mathematical Modeling of Cancer Progression
$1,137,478Vito Quaranta · Vanderbilt University · U54 · FY2010 · CA
Heterodimeric IL-15 in Cancer Immunotherapy
$1,137,140George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Penn Telehealth Research Center of Excellence in Cancer Care
$1,136,977Katharine A. Rendle · University Of Pennsylvania · P50 · FY2025 · CA
Novel bi-specific immunotherapeutic against high-threat Gram-negative pathogens
$1,136,490David S Perlin · Hackensack University Medical Center · R01 · FY2020 · AI
ADP-ribosylation Cycles
$1,136,382Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Radiation-induced molecular targets
$1,135,907Norman Coleman · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3
$1,135,499David John Hunter · Brigham And Women'S Hospital · U01 · FY2010 · CA
RESTORATION OF APOPTOSIS IN CANCER
$1,135,263University Of Texas Md Anderson Can Ctr · P01 · FY2003 · CA
2/3 Morehouse School of Medicine/Tuskegee University/ University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership
$1,134,995Timothy Turner · Tuskegee University · U54 · FY2024 · CA
Cancer Center Support Grant
$1,134,816Steven Terry Rosen · Beckman Research Institute/City Of Hope · P30 · FY2023 · CA
Relating Drugs to Genotypes to Transform Precision Cancer Therapeutics with Tuba-seq - a Novel, Highly Scalable and Quantitative Preclinical Experimental Oncology Platform
$1,134,487Ian Paul Winters · D2g Oncology, Inc. · R44 · FY2020 · CA
Single-molecule measurements of DNA topology and topoisomerases
$1,134,091Keir Neuman · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
Tumor-Stroma Interacions in the Tumor Microenvironment
$1,134,010Richard O Hynes · Massachusetts Institute Of Technology · U54 · FY2010 · CA
Mechanisms of non-classical multidrug resistance in cancer
$1,133,609Michael Gottesman · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents
$1,133,603Terrence Burke · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Washington University PDX Development and Trial Center
$1,133,597Li Ding · Washington University · U54 · FY2023 · CA
Section on High Resolution Optical Imaging
$1,133,394Hari Shroff · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2013 · EB
Collagen-related diseases
$1,133,347Sergey Leikin · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2018 · HD
Molecular Pathology of Pulmonary Carcinogenesis
$1,133,324Ilona Linnoila · Clinical Sciences · Z01 · FY2007 · CA
DNA Topoisomerases as Target of Action of Anticancer Drugs
$1,132,850Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
IMAGE AND MODEL BASED ANALYSIS OF LUNG DISEASE
$1,132,709University Of Iowa · R01 · FY2000 · HL